Sandler Capital Management’s Elevance Health ELV Stock Holding History

Sandler Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-700	Closed	-$364K	–	174
2024 Q3	$364K	Hold	700	–	–	0.05%	131
2024 Q2	$379K	Hold	700	–	–	0.04%	113
2024 Q1	$363K	Hold	700	–	–	0.03%	129
2023 Q4	$330K	Hold	700	–	–	0.03%	97
2023 Q3	$305K	Hold	700	–	–	0.03%	99
2023 Q2	$311K	Buy	+700	New	+$323K	0.03%	84
2019 Q4	–	Sell	-1,350	Closed	-$324K	–	81
2019 Q3	$324K	Buy	1,350 +350	+35%	+$95.9K	0.03%	95
2019 Q2	$282K	Buy	+1,000	New	+$273K	0.02%	131
2015 Q1	–	Sell	-35,400	Closed	-$4.45M	–	210
2014 Q4	$4.45M	Buy	+35,400	New	+$4.37M	0.23%	143

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Sandler Capital Management's ELV Position: Q4 2024 in Review

Sandler Capital Management sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 700 shares — an estimated $364K sold.

Sandler Capital Management first reported a position in ELV in Q4 2014 and held it in 9 quarters. The position peaked at $4.45M in Q4 2014. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

Sandler Capital Management reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
Sandler Capital Management sold 700 Elevance Health shares in Q4 2024, an estimated $364K.
Sandler Capital Management first reported a position in Elevance Health in Q4 2014 and held it in 9 quarters.
Sandler Capital Management's Elevance Health position peaked at $4.45M in Q4 2014.
1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Sandler Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.